期刊文献+

口服复锐明在低场MRCP检查中的应用

Role of oral Ferric Ammoxnurn Citrate Solution (Ferrimage) in low field MRCP
下载PDF
导出
摘要 目的探讨口服复锐明在低场磁共振诊断肝外胆管梗阻病变中的应用价值。方法40例受检患者随机归入本次研究,在口服复锐明(枸橼酸铁铵)前后分别行MRCP检查。结果口服复锐明后,MRCP图像级别显著性提高,达到诊断要求的图像由用药前的7.5%升至用药后的85.0%。用药前后图像级别差异有非常显著性(P<0.01)。结论口服复锐明对在低场磁共振诊断肝外胆管梗阻病变具有相当的价值,对MRCP图像质量改善具有一定意义。 Objective To probe diagnostic value of oral Ferrimage in differential diagnosis of extrahepatic biliary obstructive diseaese using low field MR. Methods 40 patients randomly underwent low field MRCP (Magnetic Resonance Cholangiopancreatography) before and after orally taking Ferrimage. Results MRCP images became improved and more acceptable for reading from 7.5% before taking Ferrimage to 85% after taking it, varying significantly (P〈0.01). Conclusion Ferrimage for oral use is very useful for diagnosing extrahepatic biliary obstructive diseases with low field MR due to improvement of image quality.
出处 《中国CT和MRI杂志》 2006年第2期37-38,共2页 Chinese Journal of CT and MRI
关键词 复锐明(枸橼酸铁铵) (MRCP)磁共振胰胆管成像 ferrimage (ferric ammonium citrate) low field MR MRCP
  • 相关文献

参考文献12

  • 1[1]Reinhold C,Bret PM.Current status of MR cholangiopan-creatograpnhy.AJR,1996,166:1285 ~ 1295.
  • 2[2]Reuther G,Kiefer B,Tuchmann A,et al.Imaging finds of pancreatobilliary duct disease with single-shot MR cholangiopan-creatography.AJR,1997,168:453~459.
  • 3[3]Hirohashi S,Hirohashi R.MR cholangiopancreatography and MR urograp:improved enhancement with a negative oral contrast agent.Radiology,1997,203:281 ~285.
  • 4[4]Hiraishi K,Narabayashi I,Fujits O,et al.Blueberry juice:preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging.Radiology,1995,194:119~123.
  • 5[1]高元桂,蔡幼铨,主编.磁共振成像诊断学.北京:人民军医出版社,1999.598.
  • 6[6]Hirohashi S,Uchida H.Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.Magn Reson Imaging,1994,12:837~846.
  • 7[7]Kivelitz D,Gehl HB.Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen.Safety and diagnostic efficacy.Acta Radiol,1999,40:429~435.
  • 8郭佑民,史大鹏,刘继汉,王泽忠,杨广夫,张明.MRI口服造影剂构橼酸铁铵的临床应用[J].西北药学杂志,1999,14(1):29-29. 被引量:1
  • 9苏壮志,李坤成.单次激发厚层投射磁共振胰胆管造影对胆系结石的诊断价值[J].中国CT和MRI杂志,2003,1(1):38-41. 被引量:26
  • 10吴晓鸣,王玉婷,曾飞雁.先天性胆管扩张症的MRCP诊断及意义[J].中国CT和MRI杂志,2004,2(4):28-30. 被引量:20

二级参考文献25

  • 1吴晓鸣,王玉婷,曾飞雁.先天性胆管扩张症的MRCP诊断及意义[J].中国CT和MRI杂志,2004,2(4):28-30. 被引量:20
  • 2戴平丰,刘继汉,余伟南.腹部磁共振成像应用口服造影剂枸橼酸铁铵的研究[J].中华放射学杂志,1994,28(6):407-411. 被引量:12
  • 3邵剑波,卢雅仁,沈杰峰,周欣.儿童先天性胆管囊肿的CT诊断(附40例报告)[J].临床放射学杂志,1997,16(1):48-50. 被引量:2
  • 4[2]Taiiri K,Takenawa H,Yamaoka K,et al. Choledochal cyst with adenocarcinoma in the cystically dilated intrahepatic bile duct.Abdom Imaging, 1997,22: 190-193.
  • 5[5]Han JK,Choi BI.Carcinoma in a choledochal cyst.Abdom Imaging,1996,21:179-181.
  • 6[2]Lopez Hanninen E,Mthauer H,Hosten N,et al. Prospective evaluation of pancreatic tunors:accuracy of MR imaging with MR holangiopancreatography and MR angiography. Radiology,2002,224: 34~ 41.
  • 7[8]Hundt W,Petsch R, Scheidler L, et al. Clinical evaluation of further-developed MRCP sequences in comparison with standard MRCP sequences. Eur Radiol, 2002,12 : 1768 ~ 1777.
  • 8[9]Guibaud L,Bret PM, Reinhold C, et al. Bile duct obstruction and choledocholithiasis: diagnosis with MR cholangiography.Radiology, 1995,197: 109~ 115.
  • 9[10]Soto JA, Yucel EK, Barish MA, et al.MR cholangiopancreatography after unsuccessful or incomplete ERCP. Radiology, 1996,199:91~98.
  • 10[4]Kim M J, Mitchell DG,Ito D,et al. Biliary dilation: differentiation of benign from malignant causes-value of adding conventional MR imaging to MRcholangiopancreatography.Radiology, 2000,214: 173~181.

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部